drugset / Trial / NCT04649242
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
RandomizedSequentialTriple-blindTreatment
Summary
The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.
Timeline
- Start
- 2021-01-15
- Primary completion
- 2029-01-09
- Completion
- 2029-01-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rimegepant | Small molecule | 50 mg | — |
| Comparator | Rimegepant | Small molecule | 75 mg | — |